Inmode Ltd
NASDAQ:INMD

Watchlist Manager
Inmode Ltd Logo
Inmode Ltd
NASDAQ:INMD
Watchlist
Price: 19.02 USD 2.89% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Inmode Ltd?
Write Note

Inmode Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Inmode Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Inmode Ltd
NASDAQ:INMD
Cash & Cash Equivalents
$403.4m
CAGR 3-Years
49%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Nano-X Imaging Ltd
NASDAQ:NNOX
Cash & Cash Equivalents
$56.4m
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Brainsway Ltd
TASE:BWAY
Cash & Cash Equivalents
$46m
CAGR 3-Years
39%
CAGR 5-Years
39%
CAGR 10-Years
16%
Sisram Medical Ltd
HKEX:1696
Cash & Cash Equivalents
$70.2m
CAGR 3-Years
-18%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Cash & Cash Equivalents
$24.4m
CAGR 3-Years
110%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Epitomee Medical Ltd
TASE:EPIT
Cash & Cash Equivalents
$15.6m
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Inmode Ltd
Glance View

Market Cap
1.6B USD
Industry
Health Care

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. The company designs, develops, manufactures and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. The Company’s proprietary technologies are used by physicians to remodel subdermal adipose, or fatty, tissue in a variety of procedures including fat reduction with simultaneous skin tightening, face and body contouring and ablative skin rejuvenation treatments. Its products target a wide array of procedures including simultaneous fat killing and skin tightening, permanent hair reduction, skin appearance and texture, among others. The Company’s products may be used on a variety of body parts, including the face, neck, abdomen, upper arms, thighs and intimate feminine regions. The company owns six product platforms: BodyTite, Optimas, Votiva, Contoura, Triton and EmbraceRF. All are market and sell traditionally to plastic and facial surgeons, aesthetic surgeons and dermatologists, among others.

INMD Intrinsic Value
23.16 USD
Undervaluation 18%
Intrinsic Value
Price

See Also

What is Inmode Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
403.4m USD

Based on the financial report for Sep 30, 2024, Inmode Ltd's Cash & Cash Equivalents amounts to 403.4m USD.

What is Inmode Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
40%

Over the last year, the Cash & Cash Equivalents growth was 39%. The average annual Cash & Cash Equivalents growth rates for Inmode Ltd have been 49% over the past three years , 40% over the past five years .

Back to Top